Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
19 stocks expected to significantly increase earnings in Q1, 3 stocks heavily bought by retail investors
In recent days, listed companies have gradually released earnings forecasts for Q1. This directly reflects industry conditions and profitability, providing important reference for investors to judge market trends and make investment decisions.
Earnings Growth in Q1 for 19 Companies
According to data from Securities Times · Data Bao, as of the close of trading on April 1, 26 listed companies have disclosed their 2026 Q1 performance through earnings forecasts, prospectuses, and other forms. Based on the lower bound of forecasted attributable net profit, 19 companies are expected to see year-over-year growth in attributable net profit, 2 are expected to turn a loss into profit, and 2 are expected to narrow losses. The overall “good news” ratio is close to nine-tenths.
Okoe Co., Ltd. and Fuxiang Pharmaceutical are both expected to post year-over-year increases in attributable net profit exceeding 2000%. Okoe Co., Ltd. expects attributable net profit of RMB 180 million to RMB 220 million, up 2248.89% to 2770.86% year over year, and is expected to hit a new high since the company’s listing. In its announcement, the company said that the main raw material for hard alloy cutting tools—tungsten carbide—has continued to rise significantly. The company has advantages in funding and scale effects, enabling both the quantity and pricing of its products to rise together.
Fuxiang Pharmaceutical expects attributable net profit of RMB 52 million to RMB 75 million, up 2222.67% to 3250.01% year over year, and is expected to record the highest single-quarter attributable net profit since 2022. The company stated that, benefiting from the continued improvement in the new energy industry’s business outlook, demand in the power battery market is growing steadily, and demand in the energy storage battery market is rapidly surging, driving sustained increases in demand for upstream lithium battery materials. The company’s lithium battery electrolyte additive business is performing well; key products such as VC, FEC, and others see both quantity and pricing rise together, thereby driving a large year-over-year increase in the company’s performance.
Performance Strength in Two Major Sub-Segments
From the perspective of sub-segments, among listed companies with positive Q1 earnings guidance, those in the general equipment and semiconductor industries are leading in number, with 3 each. Among them, all three general equipment companies’ main businesses include hard alloy and tools.
Wind data shows that as of April 1, the quote for tungsten carbide powder (purity ≥99.7%, particle size 2—10μm) is 2265 yuan per kilogram, up more than 122% from the end of 2025. With the increase in prices of the main raw material tungsten carbide, listed companies have raised prices for hard alloy and tool products, driving growth in their operating performance.
A research report from Guotou Securities argues that, in the short term, as the prices of key raw materials such as tungsten carbide powder continue to rise, the timetable for passing price increases downstream for tooling products is expected to accelerate. For leading companies that hold low-cost raw-material inventories, their profit sensitivity is expected to be more pronounced. In the long term, the continued development of China’s advanced manufacturing industry and the strong demand for a supply chain that is “independently controllable and secure” will accelerate import substitution in the tooling industry.
Semiconductor industry listed companies are all benefiting from the development of the artificial intelligence industry. Xiamuxi Co., Ltd.-U said that it is actively advancing deep integration of AI technology with various industries, and that its business scale has grown significantly compared with the same period of the prior year. Hygon Information said that as domestic high-end chips see demand increase driven by the AI industry, market demand continues to rise. The company increases investment to expand the market footprint of its high-end processor products.
Net Financing Purchases of Over RMB 100 Million for 11 Stocks
According to Data Bao statistics, as of March 31, the total amount of net financing purchases for the above 26 stocks since March reached RMB 3.7311 billion. Among them, 11 stocks had net financing purchases exceeding RMB 100 million; Demingli, Okoe Co., Ltd., and Xinrui Co., Ltd. are at the top, reaching RMB 2.476 billion, RMB 610 million, and RMB 503 million, respectively.
Demingli saw net financing purchases of RMB 2.476 billion in March. The company expects attributable net profit of RMB 3.15 billion to RMB 3.65 billion for Q1, turning a loss into a profit. Since the second half of 2025, the AI industry has continued to maintain high business conditions, driving the price cycle in the storage chip industry chain to remain on an upward trajectory. The company said that relying on abundant raw-material strategic reserves built earlier, its profitability continues to improve and its profit level has increased significantly.
Judging from secondary market performance, the stock price trends of companies that disclosed earnings forecasts have diverged significantly. For companies with positive earnings guidance, their average stock price increased 5.89% since March. Among them, Wanfangde, Demingli, and Kuncai Technology are at the top in cumulative gains, at 76.88%, 45.49%, and 38.56%, respectively. By contrast, for companies whose year-over-year earnings fell, their stock prices faced pressure, with an average decline of 10.45%.
Statement: All information contained in Data Bao does not constitute investment advice. The stock market involves risk; investors should be cautious and make prudent decisions.
Proofread by: Ran Yanqing